IRF9 and ovarian cancer: A tumor-suppressive effect of chemerin was also reported by a recent in vitro study demonstrating chemerin to reduce the growth of ovarian cancer cell spheroids via activating the release of interferon (IFN)α, leading to induction of a broad, IRF9/ISGF3-mediated anti-tumoral transcriptome response [6].